Literature DB >> 22693134

Incidence, event rates, and early outcome of stroke in Dublin, Ireland: the North Dublin population stroke study.

Peter J Kelly1, Gloria Crispino, Orla Sheehan, Lisa Kelly, Michael Marnane, Aine Merwick, Niamh Hannon, Danielle Ní Chróinín, Elizabeth Callaly, Dawn Harris, Gillian Horgan, Emma B Williams, Joseph Duggan, Lorraine Kyne, Patricia McCormack, Eamon Dolan, David Williams, Joan Moroney, Cecily Kelleher, Leslie Daly.   

Abstract

BACKGROUND AND
PURPOSE: The World Health Organization has emphasized the importance of international population-based data for unbiased surveillance of stroke incidence and outcome. To date, few such studies have been conducted using recommended gold-standard ascertainment methods. We conducted a large, population-based stroke study in Dublin, Ireland.
METHODS: Using gold-standard ascertainment methods, individuals with stroke and transient ischemic attack occurring over a 12-month period (December 1, 2005-November 30, 2006) in North Dublin were identified. Disability was assessed using the modified Rankin score and stroke severity (<72 hours) by the National Institutes of Health Stroke Scale. Stroke-related deaths were confirmed by review of medical files, death certificates, pathology, and coroner's records. Crude and standardized (to European and World Health Organization standard populations) rates of incidence, risk factors, severity, and early outcome (mortality, case-fatality, disability) were calculated, assuming a Poisson distribution for the number of events.
RESULTS: Seven hundred one patients with new stroke or transient ischemic attack were ascertained (485 first-ever stroke patients, 83 recurrent stroke patients, 133 first-ever transient ischemic attack patients). Crude frequency rates (all rates per 1000 person-years) were: 1.65 (95% CI, 1.5-1.79; first-ever stroke), 0.28 (95% CI, 0.22-0.35; recurrent stroke), and 0.45 (95% CI, 0.37-0.53; first-ever transient ischemic attack). Age-adjusted stroke rates were higher than those in 9 other recent population-based samples from high-income countries. High rates of subtype-specific risk factors were observed (atrial fibrillation, 31.3% and smoking, 29.1% in ischemic stroke; warfarin use, 21.2% in primary intracerebral hemorrhage; smoking, 53.9% in subarachnoid hemorrhage; P<0.01 for all compared with other subtypes). Compared with recent studies, 28-day case-fatality rates for primary intracerebral hemorrhage (41%; 95% CI, 29.2%-54.1%) and subarachnoid hemorrhage (46%; 95% CI, 28.8%-64.5%) were greater in Dublin.
CONCLUSIONS: Using gold-standard methods for case ascertainment, we found high incidence rates of stroke in Dublin compared with those in similar high-income countries; this is likely explained in part by high rates of subtype-specific risk factors.

Entities:  

Mesh:

Year:  2012        PMID: 22693134     DOI: 10.1161/STROKEAHA.111.645721

Source DB:  PubMed          Journal:  Stroke        ISSN: 0039-2499            Impact factor:   7.914


  11 in total

1.  Suboptimal lipid management before and after ischaemic stroke and TIA-the North Dublin Population Stroke Study.

Authors:  Danielle Ní Chróinín; Chantelle Ní Chróinín; Layan Akijian; Elizabeth L Callaly; Niamh Hannon; Lisa Kelly; Michael Marnane; Áine Merwick; Órla Sheehan; Gillian Horgan; Joseph Duggan; Lorraine Kyne; Eamon Dolan; Seán Murphy; David Williams; Peter J Kelly
Journal:  Ir J Med Sci       Date:  2018-01-24       Impact factor: 1.568

2.  Opportunistic screening for atrial fibrillation in a rural area.

Authors:  B Smyth; P Marsden; R Corcoran; R Walsh; C Brennan; K McSharry; J Clarke; P J Kelly; J Harbison
Journal:  QJM       Date:  2016-01-27

3.  Cognitive impairment six months after ischaemic stroke: a profile from the ASPIRE-S study.

Authors:  Lisa Mellon; Linda Brewer; Patricia Hall; Frances Horgan; David Williams; Anne Hickey
Journal:  BMC Neurol       Date:  2015-03-12       Impact factor: 2.474

4.  Age-Specific Vascular Risk Factor Profiles According to Stroke Subtype.

Authors:  Allard J Hauer; Ynte M Ruigrok; Ale Algra; Ewoud J van Dijk; Peter J Koudstaal; Gert-Jan Luijckx; Paul J Nederkoorn; Robert J van Oostenbrugge; Marieke C Visser; Marieke J Wermer; L Jaap Kappelle; Catharina J M Klijn
Journal:  J Am Heart Assoc       Date:  2017-05-08       Impact factor: 5.501

5.  Predictors of 30-day and 90-day mortality among hemorrhagic and ischemic stroke patients in urban Uganda: a prospective hospital-based cohort study.

Authors:  Gertrude Namale; Onesmus Kamacooko; Anthony Makhoba; Timothy Mugabi; Maria Ndagire; Proscovia Ssanyu; John Bosco M Ddamulira; Laetitia Yperzeele; Patrick Cras; Edward Ddumba; Janet Seeley; Robert Newton
Journal:  BMC Cardiovasc Disord       Date:  2020-10-08       Impact factor: 2.298

6.  Incidence and Long-Term Survival of Spontaneous Intracerebral Hemorrhage Over Time: A Systematic Review and Meta-Analysis.

Authors:  Xianqi Li; Li Zhang; Charles D A Wolfe; Yanzhong Wang
Journal:  Front Neurol       Date:  2022-03-10       Impact factor: 4.003

7.  Application of the UK foresight obesity model in Ireland: the health and economic consequences of projected obesity trends in Ireland.

Authors:  Laura Keaver; Laura Webber; Anne Dee; Frances Shiely; Tim Marsh; Kevin Balanda; Ivan J Perry; Ivan Perry
Journal:  PLoS One       Date:  2013-11-13       Impact factor: 3.240

Review 8.  Comparing Risk Factor Profiles between Intracerebral Hemorrhage and Ischemic Stroke in Chinese and White Populations: Systematic Review and Meta-Analysis.

Authors:  Chung-Fen Tsai; Niall Anderson; Brenda Thomas; Cathie L M Sudlow
Journal:  PLoS One       Date:  2016-03-18       Impact factor: 3.240

9.  Secondary prevention after ischaemic stroke: the ASPIRE-S study.

Authors:  Linda Brewer; Lisa Mellon; Patricia Hall; Eamon Dolan; Frances Horgan; Emer Shelley; Anne Hickey; David Williams
Journal:  BMC Neurol       Date:  2015-10-23       Impact factor: 2.474

10.  Trends in stroke outcomes in the last ten years in a European tertiary hospital.

Authors:  Emilio Rodríguez-Castro; Iria López-Dequit; María Santamaría-Cadavid; Susana Arias-Rivas; Manuel Rodríguez-Yáñez; José Manuel Pumar; Pablo Hervella; Esteban López-Arias; Andrés da Silva-Candal; Ana Estany; María Piñeiro-Lamas; Tomás Sobrino; Francisco Campos; Manuel Portela; Manuel Vázquez-Lima; José Castillo; Ramón Iglesias-Rey
Journal:  BMC Neurol       Date:  2018-10-03       Impact factor: 2.474

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.